METHYL 4-[[2-FLUORO-3-[(6-METHYLPYRIDIN-3-YL)CARBAMOYLAMINO]PHENYL]METHYL]PIPERAZINE-1-CARBOXYLATE, 95%, 100mg

Ethyl 3-Bromo-5-chloroimidazo[1,2-a]pyridine-2-carboxylate, 97.0%, 1g

Dimethyl 3-Nitrophthalate>99.0%(GC)25g

Thiophosphoryl Chloride>98.0%(T)25g

2-(2-Fluoro-5-(methylsulfonyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95+%, 1g

(S)-3-METHYL-2-(1-OXOISOINDOLIN-2-YL)BUTANOIC ACID, 95.0%, 10g

4-Amino-2-fluoro-5-methoxybenzonitrile, 95.0%, 10g

Pomalidomide-amido-C3-COOH, 50mg

1,10-phenanthroline monohydrate, min. 99%, pa, ACS, 5 g, glass packaging

(S)-tert-Butyl 3-oxo-2-phenylpiperazine-1-carboxylate, 95.0%, 1g

Fmoc-N-Me-Tyr(tBu)-OH, 98%, 10g

Acridine-3,6-diamine hydrochloride, 95.0%, 25g

N-[(1S,2S)-2-[[[[(1R,2R)-2-(Dimethylamino)cyclohexyl]amino]thioxomethyl]amino]-1,2-diphenylethyl]-3,5-bis(trifluoromethyl)benzenesulfonamide, 97%, 100mg